Citation Impact
Citing Papers
Atypical alveolar hyperplasia: Relationship with pulmonary adenocarcinoma, p53, and c‐erbB‐2 expression
1994
Burn wound healing and treatment: review and advancements
2015 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.
1994
Formation and Function of the Myofibroblast during Tissue Repair
2007 Standout
HPV infections and lung cancer: Table 1
2002
Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification
2011 Standout
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
Atypical Adenomatous Hyperplasia of the Lung: A Probable Forerunner in the Development of Adenocarcinoma of the Lung
2001
Burn Wound Care
2011
Bronchioloalveolar Carcinoma: The Case for Two Diseases
2008
The 2004 World Health Organization classification of lung tumors
2005 Standout
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
2006 Standout
Full-Thickness Skin Wound Healing Using Autologous Keratinocytes and Dermal Fibroblasts with Fibrin
2014
Mechanotransduction and extracellular matrix homeostasis
2014 Standout
Dermal regenerative matrix use in burn patients: A systematic review
2019
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
Lessons from Hereditary Colorectal Cancer
1996 Standout
Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein
2001
ANCA-associated vasculitides—advances in pathogenesis and treatment
2010
Gallbladder cancer: a morphological and molecular update
2009
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients
2000
Aptamers as therapeutics
2010 Standout
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
2005 Standout
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
P53 and Ki-67 antigen expression in small oral biopsy specimens of salivary gland tumors
2000
p21 in cancer: intricate networks and multiple activities
2009 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Pathology of Human Bronchioloalveolar Carcinoma and Its Relationship to the Ovine Disease
2003
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma
2006
Systemic Lupus Erythematosus
2011 Standout
APC, K‐ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall‐bladder suggest two genetic pathways in gall‐bladder carcinogenesis
1996
Clinical Implications of the p53 Tumor-Suppressor Gene
1993
Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury
2011
Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival
1998
Tenascins: regulation and putative functions during pathological stress
2003
Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
2005 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Fibulin-5/DANCE is essential for elastogenesis in vivo
2002 StandoutNatureNobel
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Salivary gland tumours
2002 Standout
Cancer/testis antigens, gametogenesis and cancer
2005 Standout
Antimicrobial strategies centered around reactive oxygen species – bactericidal antibiotics, photodynamic therapy, and beyond
2013 Standout
K‐ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers
1999
The Molecular Epidemiology of Lung Cancer
1997
Gallbladder cancer: epidemiology and outcome
2014 Standout
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
The Emerging p53 Gene Family
1999 StandoutNobel
Fibroblasts in cancer
2006 Standout
Lung adenocarcinoma and human papillomavirus infection
2004
Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers
2005
Burn injury
2020 Standout
Cell cycle control and cancer chemotherapy
1994 StandoutNobel
Epidemiology and Molecular Pathology of Gallbladder Cancer
2001
p53 immunostaining suggests that uterine carcinosarcomas are monoclonal
1994
Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer
2012 Standout
Myeloperoxidase: Molecular Mechanisms of Action and Their Relevance to Human Health and Disease
2009
Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology
2016
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
An approach to the diagnosis and management of systemic vasculitis
2010
The integrin alpha 9 beta 1 mediates cell attachment to a non-RGD site in the third fibronectin type III repeat of tenascin.
1994
Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.
2001
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
2020 Standout
Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
2002
Tissue engineering in burn scar reconstruction
2015
The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women.
2001
Mechanisms of Immune Complex–Mediated Neutrophil Recruitment and Tissue Injury
2009
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance.
1995
Works of Dia Kamel being referenced
Evidence by In Situ Hybridization that c-erbB-2 Proto-oncogene Expression Is a Marker of Malignancy and Is Expressed in Lung Adenocarcinomas
1992
Lowp53 protein expression in salivary gland tumours compared with lung carcinomas
1992
p53 immunohistochemical positivity as a prognostic marker in intracranial tumours
1994
p53 and c‐erbB‐2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder
1993
Topical negative pressure therapy: Does it accelerate neovascularisation within the dermal regeneration template, Integra? A prospective histological in vivo study
2010
Mechanisms of ANCA-Mediated Leukocyte-Endothelial Cell Interactions In Vivo
2008
Tenascin Immunoreactivity in Lung Tumors
1993
DNA Copy Number Changes in Schistosoma-Associated and Non-Schistosoma-Associated Bladder Cancer
2000
p53 Immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours
1992
Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney
2010
p53 protein accumulation and the presence of human papillomavirus dna in bronchiolo‐alveolar carcinoma correlate with poor prognosis
1995
Comparative analysis ofp53 protein immunoreactivity in prostatic, lung and breast carcinomas
1992